Amspro Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-12-2024
- Paid Up Capital ₹ 5.00 M
as on 04-12-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.14 Cr
as on 04-12-2024
- Revenue 7.55%
(FY 2022)
- Profit 45.81%
(FY 2022)
- Ebitda 13.21%
(FY 2022)
- Net Worth 8.40%
(FY 2022)
- Total Assets 11.60%
(FY 2022)
About Amspro Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.14 Cr.
Minnekanti Babu and Katepalli Sunita serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PTC069945
- Company No.
069945
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Amspro Biotech Private Limited offer?
Amspro Biotech Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Fish Foods, Animal Feed Supplement, Aqua Probiotics, Aqua Feed Supplement, Fertilizer, Bio Fertilizers.
Who are the key members and board of directors at Amspro Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Minnekanti Babu  | Director | 11-Aug-2010 | Current |
| Katepalli Sunita | Director | 11-Aug-2010 | Current |
Financial Performance of Amspro Biotech.
Amspro Biotech Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.55% increase. The company also saw a substantial improvement in profitability, with a 45.81% increase in profit. The company's net worth moved up by a moderate rise of 8.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amspro Biotech?
Unlock access to Amspro Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Amspro Lifesciences Private LimitedActive 9 years 8 monthsMinnekanti Babu and Katepalli Sunita are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Mar 2022 | ₹2.88 M | Open |
Hdfc Bank Limited Creation Date: 05 Jul 2016 | ₹8.50 M | Open |
How Many Employees Work at Amspro Biotech?
Amspro Biotech has a workforce of 36 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amspro Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amspro Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
